Tel:
Fax:
Email:
Creative Biolabs
Product
Hot Products
Antibodies
Cells
Kits
Tracers
Gene Related Products
Biospecimens
Cell Assay Reagents

NeuroMab™ Anti-CTNNB1 Antibody,Clone NR1506P

[CAT#: NRP-0422-P1101]

Host Species:
Mouse
Species Reactivity:
Human
Applications:
ELISA; WB; IHC

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Clone Number

NR1506P

Applications

ELISA; WB; IHC

Relevant Diseases

Autism Spectrum Disorder; Schizophrenia
Product Properties

Preservatives

BSA Free

Concentration

1mg/mL

Endotoxin Level

Regular Endotoxin < 5 EU/mg
Low Endotoxin < 1 EU/mg

Shipping

Gel Packs

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Research Use Only

For research use only
Target

Target

CTNNB1

Official Name

CTNNB1

Full Name

Catenin β-1

Alternative Names

CTNNB1; CTNNB; MRD19; armadillo; catenin beta 1; EVR7; NEDSDV

Uniprot ID

P35222 (Human); Q02248 (Mouse)
Product Pictures
FCM

Figure 1 shows FACS histograms of selected SIRPA antibodies binding to rodent Chinese hamster ovary cell lines (CHO) expressing human SIRPA (HuSIRPA) or mouse SIRPA (MuSIRPA). Left panel

FCM

Figure 2 shows FACS histograms of binding of selected SIRPA antibodies to primary human macrophages.

FCM

Figure 3 shows the binding of increasing concentrations of anti-SIRPA antibodies to human SIRPA overexpressed on CHO cells. EC50 values were calculated by fitting the data to a sigmoid curve using Graph Pad Prism.

Block

Figure 4 shows the ability of CD47-blocking and CD47-non-blocking anti-SIRPA antibodies to affect HuSIRPA-dependent luciferase expression in a cell-based reporter assay.

BWZ-HuSIRPA cells were seeded in wells with or without plate-bound CD47 protein. All CD47 blocking antibodies (1B3, 12D6, 1H11, 5F7) effectively inhibited the luminescence signal. Two CD47 non-blocking anti-SIRPA antibodies did not reduce luciferase expression. Results are expressed as background multiples. The background level is set to 1 on the y-axis.

Block

Figure 5 shows the induction of human SIRPA-dependent or human SIRPB1-dependent luciferase expression in a cell-based reporter assay.

FuncS

Figure 6 shows downregulation of SIRPA receptors in primary human macrophages in response to antibody stimulation.

Cells were treated with soluble full-length isotype control or soluble full-length anti-SIRPA antibody, followed by staining with DyLight650-conjugated anti-SIRPA reference antibody (SA56-DyL650) that binds to different epitope bins.

FuncS

Figure 7 shows the enhanced phagocytic activity of macrophages treated with CD47 blocking anti-SIRPA antibodies.

Macrophages were cultured overnight in 2.5% FBS RPMI medium containing 5 μg/mL 12D6, 9C5, 1H11, 5F7, 1B3, 3F9 (CD47 non-blocker) or isotype control.

FuncS

Figure 8 is a graph showing the average tumor volume of NSG mice transplanted with human immune stem cells from different cord blood donors (donors 5031, 5048, 129).

Humanized mice were implanted subcutaneously with the human breast cancer cell line MDA-MB-231, and were randomly divided into groups based on tumor volume on day -1, huCD34+ stem cell donor, body weight before randomization, and huC45+ engraftment rate before randomization. treatment group or control group. Mice were injected intraperitoneally with 40 mg/kg mouse IgG1 or 3F9 every 4 days or 10 mg/kg Keytruda every 5 days.

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Fill out this form for a quote Inquiry Form Send Inquiry
Inquiry Basket
compare

Send inquiry